Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
PUT
Ambarella
AMBA
$3.54B
| $50.4M | 0.01% |
+549,100
| New | +$38.4M |
|
1127
ScottsMiracle-Gro
SMG
$3.86B
| $50.4M | 0.01% |
252,893
-57,760
| -19% | -$9.9M |
|
1128
Macy's
M
$6.85B
| $50.4M | 0.01% |
4,475,846
-755,551
| -14% | -$6.46M |
|
1129
Onto Innovation
ONTO
$14.1B
| $50.3M | 0.01% |
1,056,894
-131,227
| -11% | -$5.26M |
|
1130
Chegg
CHGG
$113M
| $50.1M | 0.01% |
555,082
-111,693
| -17% | -$8.87M |
|
|
WRK
1131
DELISTED
WestRock Company
WRK
| $50.1M | 0.01% |
1,150,230
-644,628
| -36% | -$26.6M |
|
1132
Corpay
CPAY
$25.5B
| $50M | 0.01% |
183,431
-165,356
| -47% | -$42.5M |
|
1133
PUT
Pinduoduo
PDD
$130B
| $49.7M | 0.01% |
+280,000
| New | +$33.5M |
|
1134
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
| $49.5M | 0.01% |
482,648
-432,764
| -47% | -$41.2M |
|
1135
TriCo Bancshares
TCBK
$1.85B
| $49.4M | 0.01% |
1,398,901
-55,225
| -4% | -$1.74M |
|
1136
Western Midstream Partners
WES
$19.1B
| $49.2M | 0.01% |
3,559,649
+1,063,093
| +43% | +$12.2M |
|
1137
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $49.1M | 0.01% |
505,484
+63,106
| +14% | +$6.08M |
|
1138
Xencor
XNCR
$1.49B
| $49.1M | 0.01% |
1,124,940
+40,346
| +4% | +$1.67M |
|
1139
Silicon Laboratories
SLAB
$7.2B
| $49M | 0.01% |
384,730
+284,817
| +285% | +$32.1M |
|
1140
Idacorp
IDA
$8.22B
| $48.9M | 0.01% |
509,370
+333,619
| +190% | +$30.4M |
|
|
HES
1141
DELISTED
Hess
HES
| $48.9M | 0.01% |
926,535
-439,898
| -32% | -$20M |
|
|
ONEM
1142
DELISTED
1Life Healthcare
ONEM
| $48.9M | 0.01% |
1,120,114
-95,267
| -8% | -$3.25M |
|
1143
PROG Holdings
PRG
$1.83B
| $48.7M | 0.01% |
+903,778
| New | +$46.6M |
|
1144
Shift4
FOUR
$4.28B
| $48.7M | 0.01% |
645,577
+620,603
| +2,485% | +$37.1M |
|
1145
Teva Pharmaceuticals
TEVA
$40.6B
| $48.5M | 0.01% |
5,023,378
+484,420
| +11% | +$4.64M |
|
1146
CALL
CVS Health
CVS
$125B
| $48.4M | 0.01% |
708,600
+305,800
| +76% | +$19.9M |
|
|
IPG
1147
DELISTED
Interpublic Group of Companies
IPG
| $48.3M | 0.01% |
2,053,737
-2,144,282
| -51% | -$45M |
|
1148
Broadridge
BR
$18.8B
| $48.3M | 0.01% |
315,195
-109,891
| -26% | -$15.9M |
|
1149
British American Tobacco
BTI
$127B
| $48.3M | 0.01% |
1,287,579
+234,109
| +22% | +$8.38M |
|
1150
Lumen
LUMN
$6.31B
| $48.2M | 0.01% |
4,947,603
-7,769,559
| -61% | -$76.7M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 644 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.